Orion Oyj 2008 AR2
The report highlights Orion's financial and operational performance for the fiscal year 2008, during which the company achieved net sales of EUR 710.7 million and an operating profit of EUR 185.0 million. Key developments included expanding the market presence of its Parkinson's disease treatments, Stalevo and Comtess/Comtan, and acquiring European marketing rights for the prostate cancer drug Vantas and the overactive bladder treatment Kentera. In sustainability, Orion committed to the Energy Efficiency agreement of the Confederation of Finnish Industries, aiming to reduce energy consumption by nine percent by 2016, and joined the global Responsible Care initiative. The company also restructured its pharmaceutical R&D operations and expanded its veterinary medicine portfolio through a partnership with Pfizer.
Company: Orion Oyj
Sector: Manufacturing
Country: Finland
Year: 2008
Type: AR2
Pages: 124
Orion Oyj
The report highlights Orion's financial and operational performance for the fiscal year 2008, during which the company achieved net sales of EUR 710.7 million and an operating profit of EUR 185.0 million. Key developments included expanding the market presence of its Parkinson's disease treatments, Stalevo and Comtess/Comtan, and acquiring European marketing rights for the prostate cancer drug Vantas and the overactive bladder treatment Kentera. In sustainability, Orion committed to the Energy Efficiency agreement of the Confederation of Finnish Industries, aiming to reduce energy consumption by nine percent by 2016, and joined the global Responsible Care initiative. The company also restructured its pharmaceutical R&D operations and expanded its veterinary medicine portfolio through a partnership with Pfizer.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2008
Reporting Period
Jan 1, 2008 - Dec 31, 2008
Fiscal Year
2008
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees